Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012

被引:6
|
作者
Baviera, M. [1 ]
Avanzini, F. [1 ]
Marzona, I. [1 ]
Tettamanti, M. [2 ]
Vannini, T. [1 ]
Cortesi, L. [3 ]
Fortino, I. [4 ]
Bortolotti, A. [4 ]
Merlino, L. [4 ]
Trevisan, R. [5 ]
Roncaglioni, M. C. [1 ]
机构
[1] IRCCS, Ist Ric Farmacol Mario Negri, Lab Cardiovasc Prevent, Via Giuseppe La Masa 19, I-20156 Milan, Italy
[2] IRCCS, Ist Ric Farmacol Mario Negri, Lab Geriatr Epidemiol, Milan, Italy
[3] IRCCS, Ist Ric Farmacol Mario Negri, Lab Qual Assessment Geriatr Therapies & Serv, Milan, Italy
[4] Reg Hlth Minist, Milan, Italy
[5] Osped Riuniti Bergamo, Dept Internal Med, Diabetol Unit, Bergamo, Italy
关键词
Diabetes complications; Death; Antidiabetic drugs; Databases research; TRENDS; MELLITUS; DISEASE;
D O I
10.1016/j.numecd.2016.10.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: In contrast to the well-documented global prevalence of diabetes, much less is known about the epidemiology of cardiovascular (CV) complications in recent years. We describe the incidence of major CV events, deaths and drug prescribing patterns from 2002 to 2012 in subjects with (DM) or without diabetes mellitus (No DM). Methods and results: Subjects and outcomes were identified using linkable health administrative databases of Lombardy, a region in Northern Italy. A logistic regression model was used to compare myocardial infarction (MI), stroke, major amputation and death between DM and No DM in 2002 and 2012 and between the two index years in each population. The interaction between years and diabetes was introduced in the model. From 2002 to 2012 the incidence of major CV complications and death fell in both groups with a larger reduction among DM only for CV events: OR (95% CI) for the interaction 0.86 (0.79-0.93) for MI, 0.89 (0.82-0.96) for stroke, 0.78 (0.57-1.06) for major amputations. CV prevention drugs rose considerably from 2002 to 2012 particularly in DM and a switch towards safer antihyperglycemic drugs was also observed. Conclusions: Major CV complications and death declined from 2002 to 2012 in both DM and No DM. This might be due to a larger increase in prescriptions of CV drugs in DM and a relevant change toward recommended antihyperglycemic drugs. (C) 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:54 / 62
页数:9
相关论文
共 50 条
  • [21] The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes
    Nichols, GA
    Brown, JB
    [J]. DIABETES CARE, 2002, 25 (03) : 482 - 486
  • [22] Hospital admissions for cardiovascular complications of people with or without diabetes, Victoria, 2004-2016
    Kiburg, Katerina V.
    MacIsaac, Andrew I.
    Wilson, Andrew
    Sundararajan, Vijaya
    MacIsaac, Richard J.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2021, 215 (02) : 85 - 86
  • [23] Complications and cardiovascular risk factors in people with type 2 diabetes subjects in the International Diabetes Management Practices Study (IDMPS)
    Chan, Juliana
    Baik, Sei-Hyun
    Ferreira, Sandra
    Gagliardino, Juan Jose
    Hancu, Nicolae
    Ilkova, Hasan
    Ramachandran, Ambady
    Twigg, Stephen
    Aschner, Pablo
    [J]. DIABETES, 2006, 55 : A527 - A527
  • [24] Dietary advanced glycation end products and lipid profile in diabetes mellitus subjects with or without complications
    Luevano-Contreras, Claudia
    Chapman-Novakofsky, Karen
    [J]. FASEB JOURNAL, 2017, 31
  • [25] Cardiovascular risk and protective factors in adults with and without diabetes mellitus (Italy, 2016-19)
    Baldissera, Sandro
    Minardi, Valentina
    Masocco, Maria
    Ferrante, Gianluigi
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32 (04): : 617 - 623
  • [26] Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36)
    Yokoyama, H.
    Araki, S.
    Kawai, K.
    Hirao, K.
    Oishi, M.
    Sugimoto, K.
    Sone, H.
    Maegawa, H.
    Kashiwagi, A.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 109 (03) : 485 - 492
  • [27] Periodontitis and cardiovascular risk factors in subjects with and without type 1 diabetes: A cross sectional analysis
    Bailey, Ryan J.
    Sarkar, Anujit
    Snell-Bergeon, Janet K.
    Burkhardt, Brant R.
    Chandrasekaran, Sangeetha
    Johnson, Lonnie
    Alman, Amy C.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (07)
  • [28] Differences in Body Temperature Variability Between Subjects With and Without Diabetes and Predictive Value for Cardiovascular Events
    Amiya, Eisuke
    Watanabe, Masafumi
    Takata, Munenori
    Watanabe, Shogo
    Ozeki, Atsuko
    Watanabe, Aya
    Kawarasaki, Shuichi
    Nakao, Tomoko
    Hosoya, Yumiko
    Omori, Kazuko
    Maemura, Koji
    Hirata, Yasunobu
    Nagai, Ryozo
    Komuro, Issei
    [J]. CIRCULATION JOURNAL, 2013, 77 (07) : 1844 - 1853
  • [29] Serum Uromodulin Predicts Cardiovascular Events both in Patients With and in Subjects Without Type 2 Diabetes
    Leiherer, Andreas
    Muendlein, Axel
    Saely, Christoph H.
    Rein, Philipp
    Vonbank, Alexander
    Kinz, Elena
    Brandtner, Eva M.
    Fraunberger, Peter
    Drexel, Heinz
    [J]. DIABETES, 2016, 65 : A81 - A81
  • [30] PRECLINICAL STRUCTURAL AND FUNCTIONAL VASCULAR INVOLVEMENT IN YOUNG SUBJECTS WITH TYPE 1 DIABETES WITHOUT OVERT COMPLICATIONS
    Palombo, C.
    Kozakova, M.
    Morizzo, C.
    Gnesi, L.
    Malshi, E.
    Massart, F.
    Saggese, G.
    Federico, G.
    [J]. JOURNAL OF HYPERTENSION, 2010, 28 : E419 - E419